Programme overview 2021 edition


14 October 2021

In-person event at BioPartner Center Leiden, the Netherlands

CETCST
09:00-10:30
16:00-17:30
Plenary Opening - Chinese Life Sciences sector, landscape, hubs, opportunities & future expectations
Chair: Geeske in ’t Velt, Partner at 3EACON
Nico Schiettekatte, Counselor for Health, Welfare & Sport at Embassy of the Kingdom of the Netherlands in China
Dr. Henk Joos, General Manager at Agio Capital & Business Solutions
Javier Guodong Jia, CEO at OBIO Technology (Shanghai)Corp. Ltd. 
Dr. Steven Powell, CEO at eTheRNA immunotherapies
10:30-11:0017:30-18:00Coffee & tea break
11:00-12:3018:00-19:30
Panel discussion: Partnering with Chinese companies and/or investors
Chair: Henk Joos, General Manager at Agio Capital & Business Solutions
Robbert Görris, Director Nothern Europe at The Sovereign Group
Vijay Karwal, CFO at AffaMed Therapeutics
Dr. Nettie Buitelaar, CBO at BiosanaPharma
Mark Vaeck, CEO at Complix
12:30-13:3019:30-20:30Networking lunch
13:30-15:0020:30-22:00Best practices & experience stories, obstacles and lessons learned
Chair: Geeske in ’t Velt, Partner at 3EACON
Yong Xue, CMO at Asieris Pharmaceuticals
Dr. Pieter Gaillard, CEO at Eyesiu Medicines
Michiel Mussies, Lead Venture Support at NLC
Dr. Guus Simons, CEO at PathoFinder
15:00-15:3022:00-22:30Coffee & tea break
15:30-16:4522:30-23:45Panel discussion Route to market, from A to Z
Chair: Henk Joos, General Manager at Agio Capital & Business Solutions
Laisy Deng, Business Development Coordinator (Taiwan & South Korea) at RVO
Joost Vrancken Peeters, Partner at La Gro Geelkerken Lawyers
Geeske in ’t Velt, Partner at 3EACON
16:45-17:30
23:45-00:30Networking drinks


15 October 2021

Online programme with expert sessions and partnering meetings

CETCST

08:00-09:00
15:00-16:00
Online walk-in, network carousel
partnering meetings
09:00-09:4516:00-16:45Expert session
Funding & Venture Capital - By Agio Capital & Business Solutions
Daniel Wang, CEO at TUSPark
Michael Wang, Vice President, Overseas Investment & Business Development at Grand Pharma
Stephen Chan, Vice President at C-Bridge Capital
partnering meetings
10:00-10:45
17:00-17:45
Expert session
Business Development - By 3EACON
Erik Kakes, International Sales & Marketing director at Applikon Biotechnology
Rolyn Luo, Director at Applitech Pharma
Geeske in ’t Velt, Partner at 3EACON
partnering meetings
11:00-11:4518:00-18:45Expert session
Corporate Structuring & Compliance (Legal & Fiscal ) - By The Sovereign Group
Robbert Görris, Director Nothern Europe at The Sovereign Group
partnering meetings
12:00-12:4519:00-19:45Expert session
Differences in business environment and perspectives - By China Inroads
Valérie Hoeks, Founder of China Inroads		partnering meetings
12:45-13:3019:45-20:30Lunch break & network carousel
partnering meetings
13:30-14:1520:30-21:15Expert session
Intellectual Property - By La Gro Geelkerken Lawyers
Ye Yu, Director of China Practice at La Gro Geelkerken Lawyers
Benjamin Niemeijer, Partner at La Gro Geelkerken Lawyers		partnering meetings
14:20 - 14:40
21:20 - 21:40
Expert session 
China, Your Global Research Gateway - By Tigermed & Teddylab
James Brook, Head of EMEA at Tigermed
Dr. Tee Zhang, Co-CEO at Teddylab
partnering meetings
14:40-15:25
21:40-22:25
Expert session
A smarter path: Working with subsidies - By SISPark - Netherlands Innovation Centre
Yuanjie Yu, Operation Director at Fore Conif B.V. representing SISPARK Suzhou
partnering meetings
15:15-15:45
22:15-22:45
Online walk-out network carousel 
partnering meetings


Sponsors & Partners

Powered by

Co-sponsor
Partner

Powered by:
Hyphen Projects   

    Connect with us                  

Access Biotech China Newsletter
Contact Us
Privacy Policy
Terms & Conditions 
Chamber of Commerce: 32110979
VAT no: NL8184.34.491.B01		         
 
 
                                     
Subscribe

© Copyright 2021 by Hyphen Projects